Screening of CTP Synthase Inhibitors to Augment Antiviral Drugs for the Synergistic Treatment of COVID-19 Infections Dr. Stephen Bearne Dalhousie University Total Project Value: $25,000 Funding Partners: Nova Scotia Health Research Coalition, Nova Scotia Health, Dalhousie University, Dalhousie Medical Research Foundation (DMRF), QEII Health Sciences Centre Foundation, IWK Foundation, IWK Health Centre, Dartmouth General Hospital Foundation (DGHF) Key Words: COVID-19, screening, infections, virus, antiviral drug compounds

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2021
  • Funder

    Research Nova Scotia
  • Principal Investigator

    Dr. Stephen Bearne
  • Research Location

    N/A
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-19, screening, infections, virus, antiviral drug compounds